Compounds > 1,3-dipropyl-8-(4-sulfophenyl)xanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-(4-sulfophenyl)xanthine and Cardiovascular Diseases

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with Cardiovascular Diseases in 1 studies

1,3-dipropyl-8-(4-sulfophenyl)xanthine: adenosine receptor antagonist

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sousa, T1
Morato, M1
Fernandes, E1
Carvalho, F1
Albino-Teixeira, A1

Other Studies

1 other study available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and Cardiovascular Diseases

ArticleYear
Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors.
    Journal of enzyme inhibition and medicinal chemistry, 2004, Volume: 19, Issue:1

    Topics: Animals; Blood Pressure; Cardiovascular Diseases; Free Radical Scavengers; Hypertension; Oxidants; O

2004